Geraldine Gueron

About Geraldine Gueron
  • Proteomics is the study of proteins in a cell and their interactions with each other.
  • The overall goal of this research is to use proteomics for the identification of predictive prostate cancer disease biomarkers.
  • Dr. Gueron has demonstrated that a protein designated Heme Oxygenase-1 (HO-1) is involved in prostate cancer etiology and that it directly interacts with other cancer-causing proteins involved in cell signaling.
  • Studying the interaction of HO-1 and other cell signaling molecules is significant because it is believed to regulate the engine of prostate cancer – the androgen receptor.

What this means for patients: This novel targeted proteomics study may do two things: 1) develop a laboratory test that will predict the presence of potentially lethal prostate cancer and 2) discover targets for the treatment of advanced metastatic prostate cancer.

Award

2013 Stanley Zax-PCF Young Investigator

Geraldine Gueron, PhD

Iquibicen-Conicet (Argentina)

Mentor:

Elba Vazquez, PhD

Project Title:

Proteome-base biomarkers in prostate cancer: protein profiling using mass spectrometry, bioinformatics based approach and tissue microarray technology